NTI great results Phase I/II Rett Syndrome Clinical Trial with 93% of Patients showing Improvement,
Also has excellent Phase II/III Autism Trial Results !!!!
It also has excellent reviews:
A caregiver of a patient in the NTIRTT1 Rett Syndrome Clinical Trial commented
“She seems much more in tune to what’s going on around her, e.g. patting the dog (has NEVER done this before).”
Another caregiver of a patient in the NTIRTT1 Rett Syndrome Clinical Trial said
“She uses eye pointing, sometimes brings food / drink to an adult - this has not happened before.”
A parent of one the Autism Spectrum Disorder participant who has continued treatment past 90 weeks said:
“We are so privileged to be a part of a revolutionary study that has enabled our child to participate in everyday activities which would have been very stressful and almost impossible to do in the past. To be able to participate in school sports and camp is something we never imagined we could achieve. We are very grateful.”
A second parent of a patient on the extension study commented:
“The impact of our son’s autism has had a profound impact on our family unit.
We have had to cut back on our career’s, our social events, holidays and basic everyday activities.
To be able to participate in a study that has not only enhanced our son’s quality of life
but has also improved our lives as a family unit is remarkable in every sense."
- Forums
- ASX - Short Term Trading
- Short Term Trading Week Starting: 06 May
Short Term Trading Week Starting: 06 May, page-9
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online